filaminast code name waypda drug candidate developed table phosphodiesterase inhibitor inhibitor analog rolipram served prototype molecule several development discontinued phase ii trial showed therapeutic window narrow could dosed high enough without causing significant side effects nausea vomiting problem rolipram class httpsenwikipediaorgwikifilaminast